Dr. Katherine Scilla, MD
Claim this profileUniversity of Maryland/Greenebaum Cancer Center
Area of expertise
Lung Cancer
Katherine Scilla, MD has run 6 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Katherine Scilla, MD has run 4 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Maryland/Greenebaum Cancer Center
UM Baltimore Washington Medical Center/Tate Cancer Center
Clinical Trials Katherine Scilla, MD is currently running
Chemo-Immunotherapy + Durvalumab + Ceralasertib
for Small Cell Lung Cancer
The primary objective of this single arm study is to estimate the progression free survival of previously-untreated patients with extensive stage small cell lung cancer. Patients will receive initial chemo-immunotherapy followed by maintenance therapy with durvalumab and oral ceralasertib.
Recruiting
1 award
Phase 2
15 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
More about Katherine Scilla, MD
Clinical Trial Related
11 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Katherine Scilla, MD has experience with
- Carboplatin
- Durvalumab
- Biospecimen Collection
- Pembrolizumab
- Repotrectinib (TPX-0005)
- Nivolumab
Breakdown of trials Katherine Scilla, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Mesothelioma
Neuroendocrine Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katherine Scilla, MD specialize in?
Katherine Scilla, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Katherine Scilla, MD currently recruiting for clinical trials?
Yes, Katherine Scilla, MD is currently recruiting for 6 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Katherine Scilla, MD has studied deeply?
Yes, Katherine Scilla, MD has studied treatments such as Carboplatin, Durvalumab, Biospecimen Collection.
What is the best way to schedule an appointment with Katherine Scilla, MD?
Apply for one of the trials that Katherine Scilla, MD is conducting.
What is the office address of Katherine Scilla, MD?
The office of Katherine Scilla, MD is located at: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland/Greenebaum Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.